Re:Drug companies spend millions to keep charging high prices
by danielweber on Friday August 26, 2016 @01:51PM
(#12367968)
> Most of Mylan's drug portfolio has come from acquisitions of other companies
You say this like they aren't doing R&D. But the industry has just broken up into two sub-industries: the big firms who specialize in large-scale distribution, and the small firms who mostly die but some create the new successful drugs, and then get acquired.
You say this like they aren't doing R&D. But the industry has just broken up into two sub-industries: the big firms who specialize in large-scale distribution, and the small firms who mostly die but some create the new successful drugs, and then get acquired.